Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
33.95
-3.00 (-8.12%)
At close: Dec 5, 2025, 4:00 PM EST
34.62
+0.67 (1.97%)
After-hours: Dec 5, 2025, 7:22 PM EST
Claritev Market Cap
Claritev has a market cap or net worth of $561.05 million as of December 5, 2025. Its market cap has increased by 565.91% in one year.
Market Cap
561.05M
Enterprise Value
5.18B
1-Year Change
565.91%
Ranking
Category
Stock Price
$33.95
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $561.05M, an increase of 130.88%. That is a compound annual growth rate of 15.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 561.05M | 134.74% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |